Cube Labs S.P.A. (IT:CUBE) has released an update.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Cube Labs S.p.A. has announced the establishment of LIPOVEXA, a new spin-off aimed at developing innovative treatments for diabetes, obesity, and liver health, with a funding commitment of €500,000. The initiative, in collaboration with Professor Marco Falasca and the National Institute of Biostructures and Biosystems, seeks to leverage natural and synthetic molecules for these health challenges. This move enhances Cube Labs’ portfolio and aligns with its ESG strategy by employing sustainable production methods.
For further insights into IT:CUBE stock, check out TipRanks’ Stock Analysis page.